Evidence map›Paper›PMID 37569500›Full record

ArticleInternational journal of molecular sciences2023

Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.

Cerina Chhuon, Luis Vicente Herrera-Marcos, Shao-Yu Zhang, Cécile Charrière-Bertrand, Vincent Jung, Joanna Lipecka, Berkan Savas, Nour Nasser, André Pawlak, Hocine Boulmerka and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics.International journal of molecular sciences · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Cerina ChhuonProteomic Platform Necker, Université Paris Cité Structure Fédérative de Recherche SFR Necker US24, 75015 Paris, France.ORCID 0000-0003-1347-7492
Luis Vicente Herrera-MarcosUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0002-4665-9674
Shao-Yu ZhangUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
Cécile Charrière-BertrandUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
Vincent JungProteomic Platform Necker, Université Paris Cité Structure Fédérative de Recherche SFR Necker US24, 75015 Paris, France.ORCID 0000-0003-0530-1737
Joanna LipeckaProteomic Platform Necker, Université Paris Cité Structure Fédérative de Recherche SFR Necker US24, 75015 Paris, France.
Berkan SavasUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0001-9205-7976
Nour NasserUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
André PawlakUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0002-5486-212X
Hocine BoulmerkaUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.
Vincent AudardUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0001-5343-2550
Dil SahaliUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0003-3663-4470
Ida Chiara GuerreraProteomic Platform Necker, Université Paris Cité Structure Fédérative de Recherche SFR Necker US24, 75015 Paris, France.ORCID 0000-0002-4832-6793
Mario OlleroUniv Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France.ORCID 0000-0003-3590-706X
Inserm · FRUniversité Paris Cité · FR

Funding

Agence Biomédecine Projet de Recherche GreffeBPI France INNOVUP sub faisabilité DOS0054898/00ERA-EDTA Immunonephrology Working Group Impulsion Project 2014Fondation Avenir AP-RM-17-020Fondation du Rein Prix Jeunes ChercheursInserm Transfert Enveloppe Maturation, MARECSNI project
6 · The paper itself

Abstract

Focal and segmental glomerulosclerosis (FSGS) is a severe form of idiopathic nephrotic syndrome (INS), a glomerulopathy of presumably immune origin that is attributed to extrarenal pathogenic circulating factors. The recurrence of FSGS (rFSGS) after transplant occurs in 30% to 50% of cases. The direct analysis of patient plasma proteome has scarcely been addressed to date, mainly due to the methodological difficulties associated with plasma complexity and dynamic range. In this study, first, we compared different methods of plasma preparation, second, we compared the plasma proteomes of rFSGS and controls using two preparation methods, and third, we analyzed the early proximal signaling events in podocytes subjected to patient plasma, through a combination of phosphoproteomics and lipid-raft proteomics (raftomics). By combining immunodepletion and high pH fractionation, we performed a differential proteomic analysis of soluble plasma proteins and of extracellular vesicles (EV) obtained from healthy controls, non-INS patient controls, and rFSGS patients (n = 4). In both the soluble- and the EV-protein sets from the rFSGS patients, we found a statistically significant increase in a cluster of proteins involved in neutrophil degranulation. A group of lipid-binding proteins, generally associated with lipoproteins, was found to be decreased in the soluble set from the rFSGS patients. In addition, three amino acid transporters involved in mTORC1 activation were found to be significantly increased in the EV from the rFSGS. Next, we incubated human podocytes for 30 min with 10% plasma from both groups of patients. The phosphoproteomics and raftomics of the podocytes revealed profound differences in the proteins involved in the mTOR pathway, in autophagy, and in cytoskeleton organization. We analyzed the correlation between the abundance of plasma and plasma-regulated podocyte proteins. The observed changes highlight some of the mechanisms involved in FSGS recurrence and could be used as specific early markers of circulating-factor activity in podocytes.

Indexed as

Blood ProteinsGlomerulosclerosis, Focal SegmentalPodocytesProteomeProteomicsAdultExtracellular VesiclesFemaleHumansMaleMiddle AgedSignal TransductionBlood ProteinsProteomeextracellular vesiclesimmunodepletionlipid raftsphosphoproteomicspodocytopathyraftomics

Identifiers

PMID37569500
PMCPMC10418338
OpenAlexW4385399884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.